The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Group B Streptococcus ( Streptococcus agalactiae )
Open accessAbstract
Invasive disease due to group B Streptococcus infection ( Streptococcus agalactiae ) results in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are most frequently associated with invasive disease. Group B Streptococcus remains a continuing source of morbidity and mortality in high-risk populations, including pregnant women, neonates, and the elderly; an increasing incidence of invasive disease has been observed in nonpregnant adults. Group B Streptococcus remains the most common culture-confirmed neonatal bacterial infection in the United States and is a significant source of neonatal morbidity globally. Intrapartum antibiotic prophylaxis has reduced the incidence of early-onset neonatal disease without a notable impact on the incidence of late-onset neonatal disease. Penicillin G remains the mainstay of therapy, although reduced penicillin susceptibility has been observed in select isolates. Increased frequency of resistance to non-beta-lactam antibiotics, including clindamycin, erythromycin, and fluoroquinolones, has been observed, with some isolates demonstrating resistance to vancomycin. The development and implementation of strategies to identify hosts, treat judiciously with antimicrobials with the narrowest spectra, and prevent invasive disease, with vaccines, are essential to reduce the burden of group B Streptococcus disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,183
A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI
Lancefield, R. C. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.57.4.571 · Cited by 1,341
Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues
Stoll, B. J., Hansen, N. I., Sánchez, P. J., Faix, R. G., Poindexter, B. B., Van Meurs, K. P., Bizzarro, M. J., Goldberg, R. N., Frantz, I. D., Hale, E. C., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-2217 · Cited by 1,077
Self-citationEpidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
Phares, C. R. (2008) · JAMA · doi:10.1001/jama.299.17.2056 · Cited by 878
Baker, C. J., & Kasper, D. L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941404 · Cited by 671
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Russell, N. J., Seale, A. C., O’Driscoll, M., O’Sullivan, C., Bianchi-Jassir, F., Gonzalez-Guarin, J., Lawn, J. E., Baker, C. J., Bartlett, L., Cutland, C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix658 · Cited by 552
Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014
Schrag, S. J., Farley, M. M., Petit, S., Reingold, A., Weston, E. J., Pondo, T., Hudson Jain, J., & Lynfield, R. (2016) · Pediatrics · doi:10.1542/peds.2016-2013 · Cited by 518
Seale, A. C., Bianchi-Jassir, F., Russell, N. J., Kohli-Lynch, M., Tann, C. J., Hall, J., Madrid, L., Blencowe, H., Cousens, S., Baker, C. J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix664 · Cited by 511
Cited by
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C. J., van der Linden, M. P. G., Amin-Chowdhury, Z., Bennett, D. E., Borrow, R., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00077-7 · Cited by 546
tRNA modification landscapes in streptococci: shared losses and clade-specific adaptations
Tsui, H.-C. T., Chan, C.-K., Yuan, Y., Elias, R., Sun, J., Marchand, V., Jaroch, M., Sun, G., Manzoor, I., Kutchuashvili, A., et al. (2026) · Open Biology · doi:10.1098/rsob.250445 · Cited by 4
Metadata
- Authors
- Raabe, V. N., & Shane, A. L.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2019-04-12
- Volume
- 7
- Issue
- 2
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2923627361
- Cited by
- 330
- References
- 78
- FWCI
- 27.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Group B Streptococcus ( Streptococcus agalactiae ). https://app.cochat.ai/papers/10.1128/microbiolspec.gpp3-0007-2018
- The paper
- Raabe, V. N., & Shane, A. L. (2019). Group B Streptococcus ( Streptococcus agalactiae ). Microbiology Spectrum. https://doi.org/10.1128/microbiolspec.gpp3-0007-2018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.